In a large population of people with diabetes, the use of GLP-1 receptor agonists was not linked to an increased risk for ...

Hanmi Pharmaceutical develops obesity drugs to increase muscle while reducing fat Hanmi Pharmaceutical pioneers innovative ...

Village Health Clubs & Spas dietitian Jamie Miller shares the top foods that naturally provide your body with GLP-1 without ...

The study included nearly 2 million patients, making it the largest ever conducted on this group of glucagon-like peptide-1 ...

The newest treatment for AUD, acamprosate (Campral) was developed in France. The FDA approved the drug for abstinence ...

Ozempic is a brand-name form of semaglutide (a glucagon-like peptide-1 [GLP-1] receptor agonist ... take Ozempic if you have ever had or have a family history of medullary thyroid carcinoma ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

For people with diabetes, the use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) is associated with a reduc ...

Glucagon-like peptide-1 receptor agonist use corresponded with risk reductions for dozens of diseases and adverse health ...

Weight loss drugs like Ozempic and Wegovy have been tied in a large, national study to a drop in the risk of developing dozens of health conditions. But the semaglutide-like drugs also appear to ...

A study analyzing data from over 2 million veterans found that GLP-1 receptor agonists, popular weight-loss drugs like Ozempic and Wegovy, provide significant neurological and behavioral health ...

A new study compares the benefits and risks of taking GLP-1 medications for weight loss, including risks of dementia, ...